secwatch / observer
8-K filed September 30, 2024, 7:59 PM ET ticker VNRX CIK 0000093314
leadership confidence high sentiment positive materiality 0.50

VolitionRx appoints Dr. Ethel Rubin as independent director; board expands to 7

VOLITIONRX LTD

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Ethel Rubin

Director
VNRX · VOLITIONRX LTD
Effective
2024-09-30
Filed
September 30, 2024, 7:59 PM ET
On September 30, 2024, the Board of Directors (the “ Board ”) of VolitionRx Limited (the “ Company ”), pursuant to the Company’s Bylaws, passed a resolution to increase the size of the Board to seven (7) members and appointed Dr. Ethel Rubin to fill the new vacancy on the Board effective as of September 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Ethel Rubin was appointed as Director at VOLITIONRX LTD.

Action
appointed
Role
Director
Exact text from the filing
On September 30, 2024, the Board of Directors (the “ Board ”) of VolitionRx Limited (the “ Company ”), pursuant to the Company’s Bylaws, passed a resolution to increase the size of the Board to seven (7) members and appointed Dr. Ethel Rubin to fill the new vacancy on the Board effective as of September 30, 2024.
View on SEC.gov

VOLITIONRX LTD filing history →

Source: SEC EDGAR
accession 0001477932-24-006038
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.